The adequate safety and improved symptom burden observed with self-administration of biologic therapies at home for the management of severe asthma and chronic rhinosinusitis with nasal polyps ...
Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...
SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed. Twice-yearly injections cut total nasal polyps score by ...
A meta-analysis shows varying effectiveness of treatments in restoring smell in patients with chronic rhinosinusitis with ...
The approval was supported by data from the phase 3 POLYP 1 (N=138) and POLYP 2 (N=127) trials evaluating the efficacy and safety of Xolair in adults with nasal polyps who had an inadequate response ...
Nasal polyps are inflammatory, soft, teardrop-shaped growths that line the inside of the nose or sinuses on both sides. Not all people with polyps can be cured of them. For example, people who are ...
Nasal polyps are teardrop-shaped, soft tissue growths that form in the lining of your nasal cavity and sinuses (the hollow spaces in the bones of your face). Nasal polyps are benign, which means they ...
The 56-week OSTRO trial evaluated the efficacy and safety of benralizumab, an interleukin-5 antagonist, in 413 adult patients with severe nasal polyposis. Treatment with benralizumab was associated ...
Everyday Health on MSN
6 Symptoms of Nasal Polyps — and What You Can Do About Them
You may not be able to see nasal polyps, but that doesn’t mean you can’t sense their constant presence. In fact, more than ...
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE ® (tezepelumab-ekko) for the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive topline data from two Phase III multicenter studies ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback